Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MyMedBot is a Luxembourg-based digital health company that develops software for medical emergency response, health screening, and vaccination tracking in schools, universities, workplaces, and other campus-style settings. The company originally focused on emergency alerting for people with life-threatening conditions and later pivoted during the COVID-19 pandemic to provide daily health screening and vaccine-management tools. Its products are positioned as configurable software rather than therapeutic assets, with features including emergency notification, geolocation, privacy-focused health workflows, and administrative dashboards. MyMedBot appears to operate as a commercial HealthTech software company serving institutional customers across the U.S., Canada, Europe, and the Middle East.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MyMedBot.